Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 15, 2026
DataAggregated Company Financials
Companies9
- 7D-1.3%
- 3M6.2%
- 1Y21.7%
- YTD4.3%
Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Merck KGaA declining 2.6%. This takes the industry's 12 month performance to a gain of 22%. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Jun 2026 | €96.7b | €67.4b | €482.5m | 22.9x | 200.4x | 1.4x |
| Wed, 13 May 2026 | €90.0b | €67.9b | -€888,688,801.15 | 18.1x | -101.3x | 1.3x |
| Fri, 10 Apr 2026 | €91.1b | €67.9b | -€900,274,872.40 | 19.3x | -101.2x | 1.3x |
| Sun, 08 Mar 2026 | €86.4b | €67.9b | -€902,794,919.14 | 18.1x | -95.7x | 1.3x |
| Tue, 03 Feb 2026 | €102.1b | €68.3b | €2.9b | 17.4x | 35.6x | 1.5x |
| Thu, 01 Jan 2026 | €92.6b | €68.3b | €2.9b | 18.1x | 32.3x | 1.4x |
| Sat, 29 Nov 2025 | €83.6b | €68.5b | €2.9b | 17.5x | 29x | 1.2x |
| Mon, 27 Oct 2025 | €80.3b | €68.8b | -€439,053,836.05 | 19.2x | -183x | 1.2x |
| Wed, 24 Sep 2025 | €78.3b | €68.8b | -€438,204,667.66 | 17.9x | -178.7x | 1.1x |
| Fri, 22 Aug 2025 | €78.8b | €68.9b | -€409,703,873.07 | 17.5x | -192.3x | 1.1x |
| Sun, 20 Jul 2025 | €77.7b | €69.4b | -€283,071,598.00 | 17.4x | -274.5x | 1.1x |
| Tue, 17 Jun 2025 | €79.5b | €69.4b | -€206,268,848.00 | 18.1x | -385.3x | 1.1x |
| Thu, 15 May 2025 | €78.3b | €69.2b | -€237,208,637.00 | 18.9x | -330.2x | 1.1x |
| Sat, 12 Apr 2025 | €72.5b | €69.3b | €467.0m | 17.7x | 155.2x | 1x |
| Mon, 10 Mar 2025 | €84.5b | €69.2b | €436.0m | 21.2x | 193.7x | 1.2x |
| Wed, 05 Feb 2025 | €86.2b | €69.2b | €2.0b | 22.7x | 42.5x | 1.2x |
| Fri, 03 Jan 2025 | €82.9b | €69.2b | €2.0b | 22.6x | 41.2x | 1.2x |
| Sun, 01 Dec 2024 | €83.1b | €69.2b | €2.0b | 21.4x | 41x | 1.2x |
| Tue, 29 Oct 2024 | €95.6b | €69.4b | €1.6b | 20.6x | 61.3x | 1.4x |
| Thu, 26 Sep 2024 | €97.9b | €69.3b | €1.5b | 23.6x | 66.5x | 1.4x |
| Sat, 24 Aug 2024 | €104.4b | €69.3b | €1.5b | 31.2x | 71.6x | 1.5x |
| Mon, 22 Jul 2024 | €93.3b | €69.2b | -€303,627,757.00 | 28.9x | -307.4x | 1.3x |
| Wed, 19 Jun 2024 | €101.8b | €69.2b | -€328,028,608.00 | 21x | -310.3x | 1.5x |
| Fri, 17 May 2024 | €104.1b | €69.2b | -€312,802,180.00 | 21.7x | -332.7x | 1.5x |
| Sun, 14 Apr 2024 | €95.7b | €70.0b | -€34,208,180.00 | 20.8x | -2796.8x | 1.4x |
| Tue, 12 Mar 2024 | €97.1b | €70.0b | €6.5m | 19.7x | 14946.7x | 1.4x |
| Thu, 08 Feb 2024 | €95.9b | €70.6b | -€650,504,143.00 | 19.4x | -147.5x | 1.4x |
| Sat, 06 Jan 2024 | €99.2b | €70.6b | -€650,504,143.00 | 20x | -152.5x | 1.4x |
| Mon, 04 Dec 2023 | €102.3b | €70.6b | -€650,606,256.00 | 19x | -157.2x | 1.4x |
| Wed, 01 Nov 2023 | €104.3b | €72.1b | €4.7b | 17x | 22.3x | 1.4x |
| Fri, 29 Sep 2023 | €115.0b | €72.1b | €4.7b | 22x | 24.6x | 1.6x |
| Sun, 27 Aug 2023 | €122.1b | €72.1b | €4.7b | 22.6x | 26.2x | 1.7x |
| Tue, 25 Jul 2023 | €122.1b | €74.1b | €6.5b | 18.9x | 18.9x | 1.6x |
| Thu, 22 Jun 2023 | €118.7b | €74.1b | €6.4b | 20.3x | 18.5x | 1.6x |
Price to Earnings Ratio
18.5x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 200x which is higher than its 3-year average PE of 130x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.16% | |
| Healthcare | -0.42% | |
| Pharma | -1.28% | |
| Pharma | -1.28% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DMP Dermapharm Holding | €48.65 | 2.3% +€54.5m | 37.8% | PE16.7x | |
| BAYN Bayer | €36.19 | 0.08% +€29.5m | 31.7% | PS0.8x | |
| 93M1 MPH Health Care | €27.10 | 3.8% +€4.3m | 38.6% | PS2.3x |